Virus-Free CRISPR Knock-In of a Chimeric Antigen Receptor into KLRC1 Generates Potent Target-Specific Natural Killer Cells

被引：0
|
作者：
Shankar, Keerthana [1 ,2 ]
Zingler-Hoslet, Isabella [1 ]
Shi, Lei [3 ,4 ]
Katta, Varun [5 ]
Russell, Brittany [1 ]
Tsai, Shengdar Q. [5 ]
Capitini, Christian [3 ,4 ]
Saha, Krishanu [1 ,2 ,4 ]
机构：
[1] Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI USA
[2] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI USA
[3] Univ Wisconsin Madison, Dept Pediat, Madison, WI USA
[4] Univ Wisconsin, Carbone Canc Ctr, Sch Med & Publ Hlth, Madison, WI USA
[5] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
829
引用
收藏
页码：412 / 413
页数：2
相关论文
共 9 条
  • [1] Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells
    Shankar, Keerthana
    Zingler-Hoslet, Isabelle
    Tabima, Diana M.
    Zima, Seth
    Shi, Lei
    Gimse, Kirstan
    Forsberg, Matthew H.
    Katta, Varun
    Davis, Sage Z.
    Maldonado, Daniel
    Russell, Brittany E.
    Murtaza, Muhammed
    Tsai, Shengdar Q.
    Ayuso, Jose M.
    Capitini, Christian M.
    Saha, Krishanu
    MOLECULAR THERAPY, 2025, 33 (03) : 1014 - 1030
  • [2] CRISPR knock-in of a chimeric antigen receptor into GAPDH 3'UTR locus generates potent B7H3-specific NK-92MI cells
    Dai, Liujiang
    Zhang, Pengchao
    Niu, Xiangyun
    Peng, Xixia
    Suleiman, Rabiatu Bako
    Zhang, Guizhong
    Wan, Xiaochun
    CANCER GENE THERAPY, 2025, 32 (02) : 227 - 239
  • [3] Optimization of a Virus-Free CRISPR-Cas9 Based Platform to Produce Allogeneic Chimeric Antigen Receptor (CAR) T Cells
    Gomes de Lima, Sarah Caroline
    Cappabianca, Dan
    Forsberg, Matthew
    Capitini, Christian
    Covas, Dimas T.
    Saha, Krishanu
    de Souza, Lucas E. B.
    MOLECULAR THERAPY, 2023, 31 (04) : 612 - 613
  • [4] Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells
    Gurney, Mark
    O'Reilly, Eimear
    Corcoran, Sarah
    Brophy, Sarah
    Krawczyk, Janusz
    Otto, Neil M.
    Hermanson, David L.
    Childs, Richard W.
    Szegezdi, Eva
    O'Dwyer, Michael E.
    CYTOTHERAPY, 2022, 24 (11) : 1087 - 1094
  • [5] CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential "Off the Shelf" Therapy for Multiple Myeloma
    Stikvoort, Arwen
    Sarkar, Subhashis
    Poels, Renee
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    O'Dwyer, Michael E.
    Mutis, Tuna
    BLOOD, 2018, 132
  • [6] Primary natural killer (NK) cells expressing a C-type like lectin molecule 1 (CLL-1)-specific Chimeric Antigen Receptor (CAR) exhibit potent antigen-specific activity against acute myeloid leukemia (AML)
    Sedloev, D.
    Schanda, N.
    Schmitt, A.
    Mueller-Tidow, C.
    Schmitt, M.
    Sauer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 89 - 89
  • [7] CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma
    Stikvoort, Arwen
    van der Schans, Jort
    Sarkar, Subhashis
    Poels, Renee
    Ruiter, Ruud
    Naik, Jyoti
    Yuan, Huipin
    de Bruijn, Joost D.
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    Themeli, Maria
    Groen, Richard
    O'Dwyer, Michael
    Mutis, Tuna
    HEMASPHERE, 2021, 5 (07): : E596
  • [8] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    J Chu
    Y Deng
    D M Benson
    S He
    T Hughes
    J Zhang
    Y Peng
    H Mao
    L Yi
    K Ghoshal
    X He
    S M Devine
    X Zhang
    M A Caligiuri
    C C Hofmeister
    J Yu
    Leukemia, 2014, 28 : 917 - 927
  • [9] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    Chu, J.
    Deng, Y.
    Benson, D. M.
    He, S.
    Hughes, T.
    Zhang, J.
    Peng, Y.
    Mao, H.
    Yi, L.
    Ghoshal, K.
    He, X.
    Devine, S. M.
    Zhang, X.
    Caligiuri, M. A.
    Hofmeister, C. C.
    Yu, J.
    LEUKEMIA, 2014, 28 (04) : 917 - 927
1